|

Semaglutide (Rybelsus®) Clinical Trials

4 actively recruiting trials across 1 location

Other3 trials

Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial)
Phase 3
Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis
Phase 4
Epicardial Cardiac Fat-CT (EPIC-CT)
Phase 3

Nashville, Tennessee1 trial

GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab

Vanderbilt University Medical Center

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.